| 000 | 01923nam a22004215i 4500 | ||
|---|---|---|---|
| 001 | 978-1-908517-08-1 | ||
| 003 | DE-He213 | ||
| 005 | 20140220084517.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 111102s2010 xxk| s |||| 0|eng d | ||
| 020 |
_a9781908517081 _9978-1-908517-08-1 |
||
| 024 | 7 |
_a10.1007/978-1-908517-08-1 _2doi |
|
| 050 | 4 | _aRC681-688.2 | |
| 072 | 7 |
_aMJD _2bicssc |
|
| 072 | 7 |
_aMED010000 _2bisacsh |
|
| 082 | 0 | 4 |
_a616.12 _223 |
| 100 | 1 |
_aLip, Gregory Y H. _eauthor. |
|
| 245 | 1 | 0 |
_aHandbook of Oral Anticoagulation _h[electronic resource] / _cby Gregory Y H Lip, Eduard Shantsila. |
| 264 | 1 |
_aTarporley : _bSpringer Healthcare Ltd. : _bImprint: Springer Healthcare, _c2010. |
|
| 300 |
_aIX, 72p. 5 illus., 2 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 505 | 0 | _aThe coagulation pathway and approaches to anticoagulation -- Common clinical indications for anticoagulation -- The vitamin K antagonists and their limitations -- Haemorrhage risks, patient perspectives, and quality-of-life issues -- New oral anticoagulants -- Future directions. | |
| 520 | _aAn overview of the new oral warfarin alternatives, an important new area in therapy for cardiovascular disease, provided by a leading expert. Presented in a concise format Authored by a well-known expert Provides a user-friendly overview of the most important clinical trials | ||
| 650 | 0 | _aMedicine. | |
| 650 | 0 | _aCardiology. | |
| 650 | 1 | 4 | _aMedicine & Public Health. |
| 650 | 2 | 4 | _aCardiology. |
| 700 | 1 |
_aShantsila, Eduard. _eauthor. |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9781858734521 |
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-1-908517-08-1 |
| 912 | _aZDB-2-SME | ||
| 999 |
_c111037 _d111037 |
||